Townsquare Capital »

Halozyme Therapeutics shares owned by Townsquare Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Townsquare Capital from 13F filings

Historical chart of Townsquare Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Townsquare Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Townsquare Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 50k 40.68
2023-12-31 $1.6M 45k 36.96
2023-09-30 $1.7M 44k 38.20
2023-03-31 $524k 14k 38.19
2022-12-31 $780k 14k 56.90
2022-09-30 $276k 7.0k 39.55
2022-06-30 $460k 11k 44.02
2022-03-31 $475k 12k 39.83
2021-12-31 $202k 5.0k 40.30
2021-09-30 $248k 6.1k 40.67